Newcastle University

Publications

Year: 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 1973

• Anstee QM, Day CP. A Lipid to Treat Non-Alcoholic Fatty Liver Disease – The Dawn of ‘Lipo-Rehabilitation’?. Journal of Hepatology 2012, (epub ahead of print).
• Tudhope SJ, Wang CC, Petrie JL, Potts L, Malcomson F, Kieswich J, Yaqoob MM, Arden C, Hampson LJ, Agius L. A Novel Mechanism for Regulating Hepatic GlycogenSynthesis Involving Serotonin and Cyclin-Dependent Kinase-5. Diabetes 2012, 61(1), 49-60.
• Cork D, Lennard TWJ, Shiells EA, Tyson-Capper AJ. Alternatively spliced progesterone receptor variants exist in MDA-MB-231 cells and breast tumour tissues characterised as progesterone receptor negative. Molecular Cancer Research 2012. Submitted.
• Pearce KF, Lee SJ, Haagenson M, Petersdorf EF, Norden J, Collin MP, Klein JP, Spellman SR, Lowerson SA, Davies S, Dickinson AM. Analysis of non- HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia. Haematologica 2012. In Press.
• Jowsey PJ, Williams FM, Blain PG. DNA damage responses in cells exposed to sulphur mustard. Toxicology Letters 2012, 209(1), 1-10.
• Jowsey PA, Williams FM, Blain PG. DNA damage responses in cells exposed to sulphur mustard. Toxicol Lett 2012, 209 (1), 1-10.
• Kavanagh D, Pappworth IY, Anderson H, Hayes CM, Moore I, Hunze EM, Bennaceur K, Roversi P, Lea S, Strain L, Ward R, Plant N, Nailescu C, Goodship TH, Marchbank KJ. Factor I Autoantibodies in Patients with Atypical Hemolytic Uremic Syndrome: Disease-Associated or an Epiphenomenon?. Clinical Journal of the American Society of Nephrology 2012.
• Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Drug Metabolism Reviews 2012, 44(1), 116-126.
• Swalwell H, Latimer J, Haywood RM, Birch-Machin MA. Investigating the role of melanin in UVA/B and hydrogen peroxide-induced cellular and mitochondrial ROS production and mitochondrial DNA damage in human melanoma cells. Free Radical Biology and Medicine 2012, 52, 626-634.
• Lie MLS, May CR, Kelly T, Robson SC. Let the computer choose? - the experience of participants in a randomised preference trial of medical versus surgical termination of pregnancy. Sociology of Health and Illness 2012, (epub ahead of print).
• Kirby JA, Millar B, Shelleh A, Robson SC, Shiells EA, Tyson-Capper AJ. Mechanisms for TLR4 signalling in the human myometrium. 2012. In Preparation.
• Bell R, Glinianaia S, Tennant PGW, Bilous R, Rankin J. Peri-conception hyperglycaemia and nepthropathy are associated with risk of congenital anomalyin women with pre-existing diabetes: population-based cohort study. Diabetologia 2012, e-pub ahead of print.
• Gautrey HL, Tyson-Capper AJ. Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells. 2012. Submitted.
• Hong EA, Gautrey HL, Elliott DJ, Tyson-Capper AJ. SAFB1 and SAFB2 mediated transcriptional repression: relevance in cancer. Biochem.Soc. Trans 2012. Submitted.
• Hollingsworth K. Securing Parity, Achieving Responsibility: The Legal Support for Children Leaving Custody. Legal Studies 2012. In Press.
• Sood A, Salih S, Roh D, Lacharme-Lora L, Parry M, Hardiman B, Keehan R, Grummer R, Winterhager E, Andrews PW, Abbott C, Forbes K, Westwood M, Aplin JD, Ingham E, Papageoriou I, Berry M, Liu J, Dick AD, Garland RJ, Williams N, Singh R, Simon AK, Lewis M, Ham J, Roger L, Baird DM, Crompton LA, Caldwell MA, Swalwell H, Birch-Machin MA, Lopez-Castejon G, Randall A, Lin H, Suleiman MS, Evans WH, Newson R, Case CP. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nature nanotechnology 2012, e-publication ahead of print. In Press.
• Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JBS, Dongiovanni P, Patch J, Fracanzani A, Fargion S, Day CP, Daly AK. The SOD2 C₄₇T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies. Journal of Hepatology 2012, 56(2), 448-454.
• Armstrong JL, Martin S, Illingworth NA, Jamieson D, Neilson A, Lovat PE, Redfern CPF, Veal GJ. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide. Oncology Reports 2012, 27, 293-298. In Press.
• Lane S, Al-Zubiedi S, Hatch E, Matthews I, Jorgensen AL, Deloukas P, Daly AK, Park BK, Aarons L, Ogungbenro K, Kamali F, Hughes D, Pirmohamed M. The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors. British Journal of Clinical Pharmacology 2012, 73(1), 66-76.
• Messer B, Griffiths J, Baudouin SV. The prognostic variables predictive of mortality in patients with an exacerbation of COPD admitted to the ICU: an integrative review. QJM 2012, 105(2), 115-26.
• Daly AK. Using genome-wide association studies to identify genes important in serious adverse drug reactions. Annual Review of Pharmacology and Toxicology 2012, 52(1), 21-35.
• Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H, Heath PT, Steward CG, Smith O, O'Meara A, Kerrigan H, Mahlaoui N, Cavazzana-Calvo M, Fischer A, Moshous D, Blanche S, Pachlopnick-Schmid J, Latour S, de Saint-Basile G, Albert M, Notheis G, Rieber N, Strahm B, Ritterbusch H, Lankester A, Hartwig NG, Meyts I, Plebani A, Soresina A, Finocchi A, Pignata C, Cirillo E, Bonanomi S, Peters C, Kalwak K, Pasic S, Sedlacek P, Jazbec J, Kanegane H, Nichols KE, Hanson IC, Kapoor N, Haddad E, Cowan M, Choo S, Smart J, Arkwright PD, Gaspar HB. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 2012, 117(1), 53-62.